CFN Media Group (“CannabisFN”), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing Laguna Blends (CSE:LAG; OTCMKTS:LAGBF; FRA:LB6A) plans to acquire a leading global cannabis firm and grow into a leader in the space.
The hemp-derived cannabidiol (“CBD”) market has been growing at a rapid pace over the past few years. The Hemp Business Journal estimates that consumer CBD sales will soar more than 700% to $2.1 billion by 2020. Greenwave Advisors is even more optimistic about the growth in the CBD market, with Founder Matt Karnes telling Forbes that it could reach $3 billion by 2021 — a significant growth rate and market for emerging companies.
Laguna Blends aims to become a market leader in the distribution of hemp and CBD products by acquiring and incubating companies in the space. Recently, the company announced that it signed a letter of intent to acquire a leading cannabis firm with unaudited annual sales of $12 million and adjusted EBITDA of $1,588,000. The transaction would occur for cash and stock consideration totaling $12.5 million, making it an attractive acquisition for shareholders.
In addition to its acquisition strategy, the company owns and operates a business-to-business network of affiliates and an online marketplace lagunablends.com to extend distribution. Currently, the company sells a complete line of CBD-infused skincare products through its Cannaceuticals website at www.cbdskincream.com. These products target everything from exfoliation to anti-aging and harness the power of CBDs and other cutting-edge compounds.
The potential acquisition of a revenue-generating firm in the space could provide the financial leverage to accelerate the company’s acquisition strategy over the coming quarters as well as bolster its other internal efforts. At the same time, the company’s online marketplace and affiliate network could open the door to significant synergies between acquired companies and generate significant long-term revenue for shareholders.
Read full article:
Click here to connect with Laguna Blends (CSE:LAG; OTCMKTS:LAGBF; FRA:LB6A) to receive an Investor Presentation.
Revive Therapeutics Ltd. (“Revive”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce the appointment of Dr. Joel Moody, MD, MPH, DTM&H, as a medical and clinical advisor to the Company to assist in the expansion of clinical studies in Canada and the clinical data analysis on the ongoing U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild-moderate COVID-19.
“We would like to welcome Dr. Moody as a medical and clinical advisor to our team and we look forward to his contributions in our ongoing FDA Phase 3 clinical study as well as expanding our COVID-19 studies in Canada,” said Michael Frank, CEO of Revive. “Dr. Moody’s experience in clinical epidemiology, data analysis and research are key to our FDA Phase 3 study as we gather clinical data from patients enrolled.”
Numinus and MAPS Public Benefit Corporation announce collaboration agreement to seek approval of MDMA-assisted psychotherapy for PTSD single-arm, open-label trial
First-of-its-kind trial in Canada will pave the way for expanded MDMA-assisted treatment to support patients with posttraumatic stress disorder
Multi-year partnership designates BioSteel as new official sports drink of Philadelphia 76ers team, Training Complex, and the presenting partner of 76ers Training Camp
BioSteel today announced a multi-year deal with the Philadelphia 76ers, making the sports hydration company the official sports drink of the team. BioSteel will also serve as a partner of the Philadelphia 76ers Training Complex, and the presenting partner for 76ers Training Camp, which begins next week.
Achievements with Scalability and Compatibility Pave Way for Next Phase of Advancement
Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) is excited to announce that the Company’s holding, Arcology, a cluster-computing powered AI blockchain ecosystem with unlimited scalability, has updated its working roadmap in response to its Testnet 1.0 results